Literature DB >> 19235390

The effect of rectal heterogeneity on wall dose in high dose rate brachytherapy.

I S Kwan1, D Wilkinson, D Cutajar, M Lerch, A Rosenfeld, A Howie, J Bucci, Y Chin, V L Perevertaylo.   

Abstract

When treating prostate cancer using high dose rate (HDR) brachytherapy, overdosing the rectal wall may lead to post-treatment rectal complications. An area of concern is related to how the rectal wall dose is calculated by treatment planning systems (TPSs). TPSs are used to calculate the dose delivered to the rectal wall, but they assume that the rectum is a water-equivalent homogeneous medium of infinite size and do not consider the effect that an air-filled "empty" rectal cavity would have on the dose absorbed along the rectal wall. The aim of this research is to quantify the effect that an air cavity has on the rectal wall dose, as its presence changes the backscatter conditions in the region. The MO Skin and RADFET dosimeters proved capable of measuring absolute dose with increasing distance from the HDR Ir-192 brachytherapy source. However, the anterior rectal wall doses measured by the MOSkin and RADFET in an empty rectal cavity were 14.7 +/- 0.2% and 13.7 +/- 0.6% lower than the dose measured in a homogeneous rectal phantom. Monte Carlo simulations corroborated the experimentally obtained results, reporting a -13.2 +/- 0.6% difference. The dose measured at the posterior wall of an empty rectal cavity was between 22% and 26% greater than the dose measured in a full rectal cavity. The heterogeneity of the rectal volume appears to have a significant effect on the rectal dose when compared to calculated rectal dose.

Entities:  

Mesh:

Year:  2009        PMID: 19235390     DOI: 10.1118/1.3031111

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  8 in total

1.  Real-time eye lens dose monitoring during cerebral angiography procedures.

Authors:  M J Safari; J H D Wong; K A A Kadir; N K Thorpe; D L Cutajar; M Petasecca; M L F Lerch; A B Rosenfeld; K H Ng
Journal:  Eur Radiol       Date:  2015-05-23       Impact factor: 5.315

2.  In vivo real-time rectal wall dosimetry for prostate radiotherapy.

Authors:  Nicholas Hardcastle; Dean L Cutajar; Peter E Metcalfe; Michael L F Lerch; Vladimir L Perevertaylo; Wolfgang A Tomé; Anatoly B Rosenfeld
Journal:  Phys Med Biol       Date:  2010-07-07       Impact factor: 3.609

3.  Impact of heterogeneity-based dose calculation using a deterministic grid-based Boltzmann equation solver for intracavitary brachytherapy.

Authors:  Justin K Mikell; Ann H Klopp; Graciela M N Gonzalez; Kelly D Kisling; Michael J Price; Paula A Berner; Patricia J Eifel; Firas Mourtada
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-03-19       Impact factor: 7.038

4.  Dosimetric impact of an air passage on intraluminal brachytherapy for bronchus cancer.

Authors:  Hiroyuki Okamoto; Akihisa Wakita; Satoshi Nakamura; Shie Nishioka; Ako Aikawa; Toru Kato; Yoshihisa Abe; Kazuma Kobayashi; Koji Inaba; Naoya Murakami; Jun Itami
Journal:  J Radiat Res       Date:  2016-09-07       Impact factor: 2.724

5.  Radiochromic film dosimetry of rectal inhomogeneity and applicator attenuation in high dose rate brachytherapy of uterine cervix.

Authors:  Satish C Uniyal; Umesh C Naithani; Sunil D Sharma; Anoop K Srivastava
Journal:  J Appl Clin Med Phys       Date:  2012-01-05       Impact factor: 2.102

6.  In vivo endorectal dosimetry of prostate tomotherapy using dual MOSkin detectors.

Authors:  Sarah J Alnaghy; Shrikant Deshpande; Dean L Cutajar; Kemal Berk; Peter Metcalfe; Anatoly B Rosenfeld
Journal:  J Appl Clin Med Phys       Date:  2015-05-08       Impact factor: 2.102

7.  Characterization of MOSkin detector for in vivo skin dose measurement during megavoltage radiotherapy.

Authors:  Wei Loong Jong; Jeannie Hsiu Ding Wong; Ngie Min Ung; Kwan Hoong Ng; Gwo Fuang Ho; Dean L Cutajar; Anatoly B Rosenfeld
Journal:  J Appl Clin Med Phys       Date:  2014-09-08       Impact factor: 2.102

8.  End-to-end test and MOSFET in vivo skin dosimetry for 192Ir high-dose-rate brachytherapy of chronic psoriasis.

Authors:  Lalida Tuntipumiamorn; Pitchayut Nakkrasae; Sansanee Kongkum; Pittaya Dankulchai
Journal:  J Contemp Brachytherapy       Date:  2019-08-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.